Wealth Trust Axiom LLC Novartis Ag Transaction History

Wealth Trust Axiom LLC

  • $360 Million
  • Q3 2025

A detailed history of Wealth Trust Axiom LLC transactions in Novartis Ag stock. As of the latest transaction made, Wealth Trust Axiom LLC holds 33,159 shares of NVS stock, worth $4.36 Million. This represents 1.18% of its overall portfolio holdings.

Number of Shares
33,159
Previous 32,650 1.56%
Holding current value
$4.36 Million
Previous $3.95 Million 7.65%
% of portfolio
1.18%
Previous 1.2%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$113.5 - $129.73 $57,771 - $66,032
509 Added 1.56%
33,159 $4.25 Million
Q2 2025

Aug 13, 2025
SELL
$101.96 - $121.01 $227,880 - $270,457
-2,235 Reduced 6.41%
32,650 $3.95 Million
Q1 2025

May 14, 2025
BUY
$97.14 - $115.57 $101,997 - $121,348
1,050 Added 3.1%
34,885 $3.89 Million
Q4 2024

Feb 13, 2025
SELL
$96.78 - $117.18 $94,360 - $114,250
-975 Reduced 2.8%
33,835 $3.29 Million
Q3 2024

Nov 13, 2024
SELL
$106.13 - $120.89 $24,940 - $28,409
-235 Reduced 0.67%
34,810 $4 Million
Q2 2024

Aug 13, 2024
BUY
$92.57 - $107.37 $84,331 - $97,814
911 Added 2.67%
35,045 $3.73 Million
Q1 2024

May 10, 2024
BUY
$95.27 - $108.47 $17,624 - $20,066
185 Added 0.54%
34,134 $3.3 Million
Q4 2023

Feb 05, 2024
BUY
$92.27 - $101.54 $70,032 - $77,068
759 Added 2.29%
33,949 $3.43 Million
Q2 2023

Aug 04, 2023
SELL
$92.52 - $104.91 $925 - $1,049
-10 Reduced 0.03%
33,190 $3.35 Million
Q1 2023

May 02, 2023
SELL
$80.03 - $92.81 $1,200 - $1,392
-15 Reduced 0.05%
33,200 $3.05 Million
Q4 2022

Jan 30, 2023
SELL
$75.55 - $92.52 $156,766 - $191,979
-2,075 Reduced 5.88%
33,215 $3.01 Million
Q3 2022

Nov 02, 2022
SELL
$74.61 - $87.26 $7,461 - $8,726
-100 Reduced 0.28%
35,290 $2.68 Million
Q2 2022

Jul 27, 2022
SELL
$80.52 - $93.75 $26,571 - $30,937
-330 Reduced 0.92%
35,390 $2.99 Million
Q1 2022

May 09, 2022
SELL
$80.11 - $90.62 $4,005 - $4,531
-50 Reduced 0.14%
35,720 $3.13 Million
Q4 2021

Feb 02, 2022
SELL
$79.7 - $88.13 $10,759 - $11,897
-135 Reduced 0.38%
35,770 $3.13 Million
Q3 2021

Oct 14, 2021
SELL
$81.78 - $95.14 $10,222 - $11,892
-125 Reduced 0.35%
35,905 $2.94 Million
Q2 2021

Jul 22, 2021
SELL
$85.24 - $94.15 $89,075 - $98,386
-1,045 Reduced 2.82%
36,030 $3.29 Million
Q1 2021

Apr 14, 2021
SELL
$83.5 - $98.47 $18,370 - $21,663
-220 Reduced 0.59%
37,075 $3.17 Million
Q4 2020

Feb 04, 2021
SELL
$78.07 - $94.43 $58,474 - $70,728
-749 Reduced 1.97%
37,295 $3.52 Million
Q3 2020

Oct 21, 2020
SELL
$82.14 - $91.0 $124,442 - $137,865
-1,515 Reduced 3.83%
38,044 $3.31 Million
Q2 2020

Jul 31, 2020
SELL
$80.93 - $91.1 $89,023 - $100,210
-1,100 Reduced 2.71%
39,559 $3.46 Million
Q1 2020

Apr 10, 2020
BUY
$70.67 - $99.01 $69,751 - $97,722
987 Added 2.49%
40,659 $3.35 Million
Q4 2019

Feb 04, 2020
SELL
$84.35 - $95.37 $29,522 - $33,379
-350 Reduced 0.87%
39,672 $3.76 Million
Q3 2019

Nov 05, 2019
SELL
$85.54 - $94.26 $24,806 - $27,335
-290 Reduced 0.72%
40,022 $3.48 Million
Q2 2019

Aug 07, 2019
SELL
$75.4 - $92.8 $29,707 - $36,563
-394 Reduced 0.97%
40,312 $3.68 Million
Q1 2019

May 03, 2019
BUY
$75.32 - $86.15 $6,402 - $7,322
85 Added 0.21%
40,706 $3.91 Million
Q4 2018

Feb 01, 2019
BUY
$73.66 - $82.02 $53,771 - $59,874
730 Added 1.83%
40,621 $3.49 Million
Q3 2018

Nov 01, 2018
BUY
$66.94 - $77.43 $155,635 - $180,024
2,325 Added 6.19%
39,891 $3.44 Million
Q2 2018

Jul 30, 2018
BUY
$64.91 - $73.36 $61,015 - $68,958
940 Added 2.57%
37,566 $2.84 Million
Q1 2018

May 01, 2018
BUY
$70.39 - $84.15 $822,929 - $983,797
11,691 Added 46.89%
36,626 $2.96 Million
Q4 2017

Feb 01, 2018
SELL
$72.33 - $77.64 $2,386 - $2,562
-33 Reduced 0.13%
24,935 $2.09 Million
Q3 2017

Nov 01, 2017
BUY
$74.14 - $77.27 $1.85 Million - $1.93 Million
24,968
24,968 $2.14 Million

Others Institutions Holding NVS

# of Institutions
1,603
Shares Held
137M
Call Options Held
1.53M
Put Options Held
2.22M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $283B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Wealth Trust Axiom LLC Portfolio

Follow Wealth Trust Axiom LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Trust Axiom LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Trust Axiom LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email